Akèy › Kansè Vezik ki pa envazif miskilè › Michigan
Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Michigan
7 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan Michigan.
Vil nan Michigan
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Comprehensive Urology, Royal Oak
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06919965A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- Michigan Institute of Urology, Troy
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07309445Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
- Regents of the University of Michigan, Ann Arbor
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07144319FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Barbara Ann Karmanos Cancer Institute, Detroit
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Henry Ford Health System, Detroit
- Corewell Health Medical Group and Spectrum Health Hospitals, Grand Rapids
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
- Michigan Institute of Urology, Troy
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT05710848ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
- Michigan Institute of Urology & Solaris Health, Troy
Ap rekriteFaz 1/2
Laj 18 a 85 · Tout sèks · Mizajou Mar 27, 2026 · NCT06800963Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.